For instance, several studies suggest that amyloid deposits, a pathological feature of AD, can trigger activation of JNK and p38 with associated tau pathology that were reduced following immunization trials against amyloid-β peptides in both Tg2576 AD mouse model and human AD brains54. This evidence concerns the gene MAPT and Alzheimer disease.